Alliança Saúde e Participações S.A.

BOVESPA:AALR3 Stock Report

Market Cap: R$1.2b

Alliança Saúde e Participações Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Alliança Saúde e Participações.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth26.6%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

Risks Still Elevated At These Prices As Alliança Saúde e Participações S.A. (BVMF:AALR3) Shares Dive 26%

Dec 05
Risks Still Elevated At These Prices As Alliança Saúde e Participações S.A. (BVMF:AALR3) Shares Dive 26%

Alliança Saúde e Participações S.A. (BVMF:AALR3) Stock Rockets 36% As Investors Are Less Pessimistic Than Expected

Aug 25
Alliança Saúde e Participações S.A. (BVMF:AALR3) Stock Rockets 36% As Investors Are Less Pessimistic Than Expected

Optimistic Investors Push Alliança Saúde e Participações S.A. (BVMF:AALR3) Shares Up 60% But Growth Is Lacking

Jul 11
Optimistic Investors Push Alliança Saúde e Participações S.A. (BVMF:AALR3) Shares Up 60% But Growth Is Lacking

What Alliança Saúde e Participações S.A.'s (BVMF:AALR3) 26% Share Price Gain Is Not Telling You

Apr 17
What Alliança Saúde e Participações S.A.'s (BVMF:AALR3) 26% Share Price Gain Is Not Telling You

Centro de Imagem Diagnósticos (BVMF:AALR3) Will Be Hoping To Turn Its Returns On Capital Around

Aug 17
Centro de Imagem Diagnósticos (BVMF:AALR3) Will Be Hoping To Turn Its Returns On Capital Around

Why Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) Could Be Worth Watching

Jul 08
Why Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) Could Be Worth Watching

Is Centro de Imagem Diagnósticos (BVMF:AALR3) Using Too Much Debt?

May 28
Is Centro de Imagem Diagnósticos (BVMF:AALR3) Using Too Much Debt?

What Is Centro de Imagem Diagnósticos S.A.'s (BVMF:AALR3) Share Price Doing?

Apr 05
What Is Centro de Imagem Diagnósticos S.A.'s (BVMF:AALR3) Share Price Doing?

Reflecting on Centro de Imagem Diagnósticos' (BVMF:AALR3) Share Price Returns Over The Last Three Years

Mar 10
Reflecting on Centro de Imagem Diagnósticos' (BVMF:AALR3) Share Price Returns Over The Last Three Years

Should You Buy Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) For Its Dividend?

Feb 17
Should You Buy Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) For Its Dividend?

What Percentage Of Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) Shares Do Insiders Own?

Jan 27
What Percentage Of Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) Shares Do Insiders Own?

Would Centro de Imagem Diagnósticos (BVMF:AALR3) Be Better Off With Less Debt?

Jan 06
Would Centro de Imagem Diagnósticos (BVMF:AALR3) Be Better Off With Less Debt?

What Does Centro de Imagem Diagnósticos S.A.'s (BVMF:AALR3) Share Price Indicate?

Dec 11
What Does Centro de Imagem Diagnósticos S.A.'s (BVMF:AALR3) Share Price Indicate?

Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) Is Yielding 0.8% - But Is It A Buy?

Aug 07
Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) Is Yielding 0.8% - But Is It A Buy?

Centro de Imagem Diagnósticos S.A.'s (BVMF:AALR3) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Jul 20
Centro de Imagem Diagnósticos S.A.'s (BVMF:AALR3) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Is Centro de Imagem Diagnósticos (BVMF:AALR3) Likely To Turn Things Around?

Jul 03
Is Centro de Imagem Diagnósticos (BVMF:AALR3) Likely To Turn Things Around?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Alliança Saúde e Participações has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

BOVESPA:AALR3 - Analysts future estimates and past financials data (BRL Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/20241,205-165107197N/A
6/30/20241,189-21886167N/A
3/31/20241,171-270-1963N/A
12/31/20231,180-22811102N/A
9/30/20231,154-263-6057N/A
6/30/20231,132-287-7750N/A
3/31/20231,100-24780206N/A
12/31/20221,085-22874187N/A
9/30/20221,092-135157261N/A
6/30/20221,110-55171270N/A
3/31/20221,127-3222124N/A
12/31/20211,137-649149N/A
9/30/20211,1603870167N/A
6/30/20211,1212958145N/A
3/31/2021978-6646116N/A
12/31/2020929-9751118N/A
9/30/2020898-10367132N/A
6/30/2020915-84120187N/A
3/31/20201,04710152228N/A
12/31/20191,07341138213N/A
9/30/20191,06950151230N/A
6/30/20191,07347111188N/A
3/31/20191,0764394177N/A
12/31/20181,0774075161N/A
9/30/20181,0741046133N/A
6/30/20181,0879N/A157N/A
3/31/20181,0828N/A144N/A
12/31/20171,0787N/A134N/A
9/30/20171,08136N/A112N/A
6/30/20171,04226N/A101N/A
3/31/20171,01513N/A81N/A
12/31/201695115N/A79N/A
9/30/201687427N/A89N/A
6/30/2016806-3N/A97N/A
3/31/201673456N/A111N/A
12/31/2015700-13N/A99N/A
12/31/2014393-4N/A48N/A
12/31/201327628N/A17N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if AALR3's forecast earnings growth is above the savings rate (10.4%).

Earnings vs Market: Insufficient data to determine if AALR3's earnings are forecast to grow faster than the BR market

High Growth Earnings: Insufficient data to determine if AALR3's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if AALR3's revenue is forecast to grow faster than the BR market.

High Growth Revenue: Insufficient data to determine if AALR3's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if AALR3's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 07:48
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Alliança Saúde e Participações S.A. is covered by 8 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Pedro MarianiBofA Global Research
Carlos Palhares SequeiraBTG Pactual
Giovana ScottiniEleven Financial Research